The evolvement of the newly started subsection IJMS molecular oncology is discussed. The breadth and depth of the journal articles is alluded to. A bright future for this subsection is anticipated, developing into a top tier cancer journal
Clinical oncology is going through a period of profound change. Targeted therapy, and more recently ...
Introduction to the Special issue “Advances in Molecular Oncology and personalized medicine: individ...
The number of papers regarding the molecular and genetic aspects of a number of different pathologic...
The evolvement of the newly started subsection IJMS molecular oncology is discussed. The breadth and...
We sincerely thank our distinguished international editorial board for their efforts on behalf of th...
The purpose of this first Special Issue is to provide a glance at the molecular advances in cancer g...
With your experiments and analyses completed, thoughts turn to writing up your work and submitting f...
Cancer is a pathological condition in which an assemblage of cells display uncontrolled growth, inva...
These authors have contributed equally to this work. Specialty section: This article was submitted t...
Contains fulltext : 170918.pdf (publisher's version ) (Open Access)Translational o...
Three weeks ago Pamir Atagunduz, the Chief Editor ofMarmara Medical Journal, talked to me about his ...
During the past quarter century or so, much effort has been devoted toward the understanding of the ...
The isolation of the first human oncogene (HRAS), a critical breakthrough in cancer research, has oc...
In recent years, the field of oncology has witnessed the unprecedented pace of genomics discovery, k...
Journal of Cell and Molecular Research (JCMR) was first published in 2008 as the first journal in th...
Clinical oncology is going through a period of profound change. Targeted therapy, and more recently ...
Introduction to the Special issue “Advances in Molecular Oncology and personalized medicine: individ...
The number of papers regarding the molecular and genetic aspects of a number of different pathologic...
The evolvement of the newly started subsection IJMS molecular oncology is discussed. The breadth and...
We sincerely thank our distinguished international editorial board for their efforts on behalf of th...
The purpose of this first Special Issue is to provide a glance at the molecular advances in cancer g...
With your experiments and analyses completed, thoughts turn to writing up your work and submitting f...
Cancer is a pathological condition in which an assemblage of cells display uncontrolled growth, inva...
These authors have contributed equally to this work. Specialty section: This article was submitted t...
Contains fulltext : 170918.pdf (publisher's version ) (Open Access)Translational o...
Three weeks ago Pamir Atagunduz, the Chief Editor ofMarmara Medical Journal, talked to me about his ...
During the past quarter century or so, much effort has been devoted toward the understanding of the ...
The isolation of the first human oncogene (HRAS), a critical breakthrough in cancer research, has oc...
In recent years, the field of oncology has witnessed the unprecedented pace of genomics discovery, k...
Journal of Cell and Molecular Research (JCMR) was first published in 2008 as the first journal in th...
Clinical oncology is going through a period of profound change. Targeted therapy, and more recently ...
Introduction to the Special issue “Advances in Molecular Oncology and personalized medicine: individ...
The number of papers regarding the molecular and genetic aspects of a number of different pathologic...
DOI
Add to ORKG